JAMP CEPHALEXIN SUSPENSION: Suspendability out of specification
Last updated
Summary
Product
JAMP Cephalexin Suspension; 125 mg/5 mL Cephalexin For Oral Suspension USP
Issue
Health products - Product quality
What to do
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Distribution
National
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot numbers |
|---|---|---|---|---|---|
JAMP Cephalexin Suspension; 125 mg/5 mL Cephalexin For Oral Suspension USP |
JAMP Cephalexin Suspension; 125 mg/5 mL Cephalexin For Oral Suspension USP |
DIN 02528436 |
Powder for suspension |
CEPHALEXIN (CEPHALEXIN MONOHYDRATE) 125mg / 5mL |
Lots # C4842001 (Exp 2025-09) & C4842003 (Exp 2025-10) |
Issue
The suspendability for Cephalexin may be out of specification in the affected lots.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Jamp Pharma Corporation
1310 rue Nobel
Boucherville, QC
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type III
Identification number
RA-75276
Get notified
Receive notifications for new and updated recalls and alerts by category.